These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12200670)

  • 1. CD34(+) or CD34(-): which is the more primitive?
    Engelhardt M; Lübbert M; Guo Y
    Leukemia; 2002 Sep; 16(9):1603-8. PubMed ID: 12200670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who is hematopoietic stem cell: CD34+ or CD34-?
    Pei X
    Int J Hematol; 1999 Dec; 70(4):213-5. PubMed ID: 10643145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
    Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
    Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection.
    Sonoda Y
    J Autoimmun; 2008 May; 30(3):136-44. PubMed ID: 18243660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human hematopoietic stem cell populations.
    Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
    Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells.
    Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ
    Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fms-related tyrosine kinase 3 expression discriminates hematopoietic stem cells subpopulations with differing engraftment-potential: identifying the most potent combination.
    Huang Y; Ratajczak MZ; Reca R; Xu H; Tanner M; Rezzoug F; Hussain LR; Fugier-Vivier I; Bolli R; Ildstad ST
    Transplantation; 2008 Apr; 85(8):1175-84. PubMed ID: 18431239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cells can be CD34+ or CD34-.
    Donnelly DS; Krause DS
    Leuk Lymphoma; 2001 Jan; 40(3-4):221-34. PubMed ID: 11426544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cells from different sources: biological and technical aspects.
    Bertolini F; Battaglia M; Lanza A; Palermo B; Cuomo A; Preti P; Robustelli della Cuna G
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S5-7. PubMed ID: 9630315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells.
    Layton DS; Strom AD; O'Neil TE; Broadway MM; Stephenson GL; Morris KR; Muralitharan M; Sandrin MS; Ierino FL; Bean AG
    Exp Hematol; 2007 Jan; 35(1):171-8. PubMed ID: 17198886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
    Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
    Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34- fractions of Thy-1lowLin-/lowSca-1+ bone marrow cells.
    Morel F; Galy A; Chen B; Szilvassy SJ
    Exp Hematol; 1998 May; 26(5):440-8. PubMed ID: 9590662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
    Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
    Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
    Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
    Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
    Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
    Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
    Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
    Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.